Allopurinol Tablets IP 300 mg Exporter in India – Healthy Inc

Allopurinol Tablets IP 300 mg | Exporter
Product image for Allopurinol Tablets IP 300 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Allopurinol |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antigout drugs |
| Subcategory | Antigout drugs |
| Active Ingredient | Allopurinol |
| Strength | 300 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antigout drugs |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Allopurinol Tablets IP 300 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Relief of pain and functional stiffness in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 2. Management of acute painful musculoskeletal disorders, tenosynovitis, lumbago, dentalgia, and post-traumatic injury. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Allopurinol Tablets IP 300 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Allopurinol Tablets IP 300 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally with a full glass of water, preferably with or immediately following meals to minimize gastric irritation. Do not exceed the maximum prescribed daily dosage. Use the lowest effective dose for the shortest treatment duration necessary. | ||||||||||||||||||||||||
| Side Effects | Common: Epigastric discomfort, dyspepsia, heartburn, nausea, abdominal pain. Uncommon: Dizziness, headache, mild diarrhea, flatulence, constipation. Rare: Peptic ulceration, gastrointestinal hemorrhage, elevated transaminases, hypersensitivity rash. | ||||||||||||||||||||||||
| Warnings and Precautions | Gastrointestinal Safety: Long-term administration can lead to gastric mucosal erosion, ulceration, or bleeding. Cardiovascular & Renal Caution: Use with caution in patients with preexisting hypertension, congestive heart failure, or renal compromise. Monitor renal parameters periodically. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Allopurinol, aspirin, or other NSAIDs. 2. Active peptic ulcer disease, gastrointestinal hemorrhage, or history of perforation. 3. Severe heart failure (NYHA Class III-IV), severe hepatic cirrhosis, or advanced renal failure. 4. Third trimester of pregnancy. | ||||||||||||||||||||||||
| Drug Interactions | 1. Anticoagulants & Antiplatelets (Warfarin, Clopidogrel): Increased risk of serious GI bleeding. 2. ACE Inhibitors, ARBs & Diuretics: Attenuated antihypertensive efficacy and increased nephrotoxicity risk. 3. Methotrexate & Lithium: Reduced renal clearance causing elevated serum concentrations and toxicity. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Allopurinol Tablets IP 300 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Allopurinol Tablets IP 300 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Allopurinol Tablets IP 300 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Allopurinol Tablets IP 300 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Allopurinol Tablets IP 300 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Allopurinol Tablets BP 300 mg ExporterView product →
✚
Allopurinol Tablets BP 300 mg ManufacturerView product →
✚
Allopurinol Tablets BP 300 mg SupplierView product →
✚
Allopurinol Tablets IP 100 mg ExporterView product →
✚
Allopurinol Tablets IP 100 mg ManufacturerView product →
✚
Allopurinol Tablets IP 100 mg SupplierView product →
✚
Allopurinol Tablets IP 300 mg ManufacturerView product →
✚
Allopurinol Tablets IP 300 mg SupplierView product →
